Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A physiology-informed microRNA framework for urothelial carcinoma in hemodialysis patients.

Renal failure·2026
Same author

Association between fluid status and small airway dysfunction in hemodialysis patients: A prospective paired study.

Respiratory physiology & neurobiology·2026
Same author

Epitranscriptomics in kidney disease: insights and therapeutic potential.

Kidney research and clinical practice·2026
Same author

Heart Failure Phenotypes and the Prognostic Utility of NT-proBNP in Patients With Chronic Kidney Disease: A Propensity-Score Matched Cohort Study.

Mayo Clinic proceedings·2026
Same author

Aldehyde dehydrogenase 2 mitigates acrolein-driven ferroptosis to preserve kidney function.

Environmental pollution (Barking, Essex : 1987)·2025
Same author

Mannitol for prevention of cisplatin-induced nephrotoxicity: a systematic review and meta-analysis of randomized controlled trials.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025

Related Experiment Video

Updated: May 24, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Abnormal thyroid function predicts mortality in patients receiving long-term peritoneal dialysis: a case-controlled

Yen-Chung Lin1, Yi-Chun Lin, Tzen-Wen Chen

  • 1Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan, ROC.

Journal of the Chinese Medical Association : JCMA
|February 21, 2012
PubMed
Summary

Abnormal thyroid function in long-term peritoneal dialysis (PD) patients is linked to a worse prognosis and increased mortality. Early detection of thyroid dysfunction and inflammation is crucial for improving survival in these individuals.

Related Experiment Videos

Last Updated: May 24, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Area of Science:

  • Nephrology
  • Endocrinology
  • Internal Medicine

Background:

  • The incidence of abnormal thyroid function is increasing in patients with chronic kidney disease undergoing long-term peritoneal dialysis (PD).
  • Understanding the clinical impact of abnormal thyroid function in this growing patient population is essential.

Purpose of the Study:

  • To investigate the clinical impact of abnormal thyroid function on patient survival in long-term PD patients.
  • To identify predictors of survival and associated factors in PD patients with abnormal thyroid function.

Main Methods:

  • A retrospective, case-controlled, longitudinal study was conducted.
  • Data on patient characteristics, laboratory results, dialysis parameters, and thyroid/cardiac function were collected from patients on PD for over 8 years.
  • Abnormal thyroid function was defined as primary hypothyroidism or sick euthyroid syndrome, excluding hyperthyroidism and recent infections/inflammatory conditions.

Main Results:

  • Of 46 patients, 41.3% exhibited abnormal thyroid function.
  • Abnormal thyroid function was an independent predictor of poor cumulative survival (HR=7.633, p=0.02), even after adjusting for covariates.
  • Lower free thyroxine levels correlated with higher C-reactive protein (CRP) levels (r=-0.547, p=0.01), and sepsis was the leading cause of death.

Conclusions:

  • Long-term PD patients with abnormal thyroid function demonstrate significantly poorer cumulative survival.
  • A strong association exists between low thyroid hormone levels, elevated CRP, and a proinflammatory state in PD patients.
  • Clinicians should monitor for abnormal thyroid function and inflammation in patients undergoing long-term PD to improve patient outcomes.